Compare PCVX & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCVX | BIRK |
|---|---|---|
| Founded | 2013 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 8.8B |
| IPO Year | 2020 | 2023 |
| Metric | PCVX | BIRK |
|---|---|---|
| Price | $48.15 | $42.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $101.67 | $65.50 |
| AVG Volume (30 Days) | 1.5M | ★ 2.8M |
| Earning Date | 11-04-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | N/A | ★ 2.19 |
| Revenue | N/A | ★ $2,460,904,611.00 |
| Revenue This Year | N/A | $16.09 |
| Revenue Next Year | N/A | $15.69 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | ★ 16.22 |
| 52 Week Low | $27.66 | $38.16 |
| 52 Week High | $93.77 | $62.66 |
| Indicator | PCVX | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 47.70 |
| Support Level | $42.40 | $40.07 |
| Resistance Level | $48.65 | $44.15 |
| Average True Range (ATR) | 1.75 | 1.82 |
| MACD | 0.16 | -0.25 |
| Stochastic Oscillator | 92.34 | 31.03 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).